• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于影响新冠病毒传播和死亡率因素的疫苗接种标准

Vaccination Criteria Based on Factors Influencing COVID-19 Diffusion and Mortality.

作者信息

Spassiani Ilaria, Gubian Lorenzo, Palù Giorgio, Sebastiani Giovanni

机构信息

Istituto Nazionale di Geofisica e Vulcanologia, 00143 Rome, Italy.

UOC Sistemi Informativi Azienda Zero-Regione del Veneto, 35131 Padua, Italy.

出版信息

Vaccines (Basel). 2020 Dec 15;8(4):766. doi: 10.3390/vaccines8040766.

DOI:10.3390/vaccines8040766
PMID:33334007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7765372/
Abstract

SARS-CoV-2 is highly contagious, rapidly turned into a pandemic, and is causing a relevant number of critical to severe life-threatening COVID-19 patients. However, robust statistical studies of a large cohort of patients, potentially useful to implement a vaccination campaign, are rare. We analyzed public data of about 19,000 patients for the period 28 February to 15 May 2020 by several mathematical methods. Precisely, we describe the COVID-19 evolution of a number of variables that include age, gender, patient's care location, and comorbidities. It prompts consideration of special preventive and therapeutic measures for subjects more prone to developing life-threatening conditions while affording quantitative parameters for predicting the effects of an outburst of the pandemic on public health structures and facilities adopted in response. We propose a mathematical way to use these results as a powerful tool to face the pandemic and implement a mass vaccination campaign. This is done by means of priority criteria based on the influence of the considered variables on the probability of both death and infection.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)具有高度传染性,迅速演变成一场大流行,导致相当数量的新冠肺炎患者病情危急甚至危及生命。然而,针对大量患者群体进行的、可能有助于开展疫苗接种运动的有力统计研究却很少见。我们运用多种数学方法分析了2020年2月28日至5月15日期间约19000名患者的公开数据。确切地说,我们描述了包括年龄、性别、患者护理地点和合并症在内的多个变量的新冠肺炎病情发展情况。这促使我们考虑针对更易发展为危及生命状况的人群采取特殊的预防和治疗措施,同时为预测大流行爆发对公共卫生结构和设施的影响以及相应采取的应对措施提供量化参数。我们提出一种数学方法,将这些结果用作应对大流行和开展大规模疫苗接种运动的有力工具。这是通过基于所考虑变量对死亡和感染概率的影响的优先标准来实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/9de214b9841b/vaccines-08-00766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/6dc02fb5f4c1/vaccines-08-00766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/245fee8733d0/vaccines-08-00766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/524bfbc6e223/vaccines-08-00766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/7ed2c90fc1b5/vaccines-08-00766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/9de214b9841b/vaccines-08-00766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/6dc02fb5f4c1/vaccines-08-00766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/245fee8733d0/vaccines-08-00766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/524bfbc6e223/vaccines-08-00766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/7ed2c90fc1b5/vaccines-08-00766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f74c/7765372/9de214b9841b/vaccines-08-00766-g005.jpg

相似文献

1
Vaccination Criteria Based on Factors Influencing COVID-19 Diffusion and Mortality.基于影响新冠病毒传播和死亡率因素的疫苗接种标准
Vaccines (Basel). 2020 Dec 15;8(4):766. doi: 10.3390/vaccines8040766.
2
COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App.使用改进的贝特曼易感-感染-恢复模型及德国海德堡观测数据进行的COVID-19大流行预测:接种SARS-CoV-2疫苗、冠状病毒检测及应用新冠警示应用程序的影响
Int J Clin Pharmacol Ther. 2020 Aug;58(8):417-425. doi: 10.5414/CP203846.
3
Stigma and Discrimination (SAD) at the Time of the SARS-CoV-2 Pandemic.SARS-CoV-2 大流行时期的污名化和歧视(SAD)。
Int J Environ Res Public Health. 2020 Aug 31;17(17):6341. doi: 10.3390/ijerph17176341.
4
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.在新冠疫情期间使用卡介苗增强医护人员的非特异性防护:丹麦一项随机对照试验研究方案的结构化总结
Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.
5
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform.计算机模拟试验测试 COVID-19 候选疫苗:以 UISS 平台为例的研究。
BMC Bioinformatics. 2020 Dec 14;21(Suppl 17):527. doi: 10.1186/s12859-020-03872-0.
6
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
7
Pandemic preparedness of dentists against coronavirus disease: A Saudi Arabian experience.牙医应对冠状病毒病的大流行准备:沙特阿拉伯的经验。
PLoS One. 2020 Aug 19;15(8):e0237630. doi: 10.1371/journal.pone.0237630. eCollection 2020.
8
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.疫苗接种对预防 COVID-19 的潜在影响:基本原理、临床证据、风险和公共卫生考虑。
Expert Rev Vaccines. 2020 Oct;19(10):919-936. doi: 10.1080/14760584.2020.1825951. Epub 2020 Oct 6.
9
Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).外科感染学会关于成人严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染者手术和围手术期护理的指南。
Surg Infect (Larchmt). 2020 May;21(4):301-308. doi: 10.1089/sur.2020.101. Epub 2020 Apr 20.
10
Preparedness and Responses Faced during the COVID-19 Pandemic in Belgium: An Observational Study and Using the National Open Data.比利时在 COVID-19 大流行期间的准备和应对措施:一项观察性研究和利用国家开放数据。
Int J Environ Res Public Health. 2020 Oct 30;17(21):7985. doi: 10.3390/ijerph17217985.

引用本文的文献

1
New Insights into the Estimation of Reproduction Numbers during an Epidemic.疫情期间繁殖数估计的新见解
Vaccines (Basel). 2022 Oct 25;10(11):1788. doi: 10.3390/vaccines10111788.
2
Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case study.优化 COVID-19 疫苗的空间分配的最优控制:以意大利为例。
PLoS Comput Biol. 2022 Jul 8;18(7):e1010237. doi: 10.1371/journal.pcbi.1010237. eCollection 2022 Jul.
3
Spatiotemporal Analysis of COVID-19 Incidence Data.COVID-19 发病数据的时空分析。

本文引用的文献

1
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response.目前处于临床前和临床研究阶段的新冠病毒疫苗及相关抗病毒免疫反应
Vaccines (Basel). 2020 Nov 3;8(4):649. doi: 10.3390/vaccines8040649.
2
COVID-19 cumulative incidence, intensive care, and mortality in Italian regions compared to selected European countries.意大利各地区与部分欧洲国家 COVID-19 累计发病率、重症监护和死亡率比较。
Int J Infect Dis. 2021 Jan;102:363-368. doi: 10.1016/j.ijid.2020.10.070. Epub 2020 Oct 30.
3
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Viruses. 2021 Mar 11;13(3):463. doi: 10.3390/v13030463.
4
COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey.刚果民主共和国的新冠疫苗接种意愿:一项横断面调查
Vaccines (Basel). 2021 Feb 14;9(2):153. doi: 10.3390/vaccines9020153.
COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
4
Cytokine Storms: Understanding COVID-19.细胞因子风暴:了解 COVID-19。
Immunity. 2020 Jul 14;53(1):19-25. doi: 10.1016/j.immuni.2020.06.017. Epub 2020 Jun 28.
5
Coagulopathy in COVID-19.新型冠状病毒疾病中的凝血功能障碍。
J Thromb Haemost. 2020 Sep;18(9):2103-2109. doi: 10.1111/jth.14975. Epub 2020 Jul 21.
6
Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?诊断性能和阈值:血清学 SARS-CoV-2 检测方法协调的关键?
Clin Chim Acta. 2020 Oct;509:1-7. doi: 10.1016/j.cca.2020.05.050. Epub 2020 May 30.
7
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
8
Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2).天然产物对 II 型跨膜丝氨酸蛋白酶(TMPRSS2),即冠状病毒 2(SARS-CoV-2)的启动剂的虚拟筛选。
Molecules. 2020 May 12;25(10):2271. doi: 10.3390/molecules25102271.
9
Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate.检测率的变化可能掩盖新型冠状病毒病(COVID-19)的增长率。
Int J Infect Dis. 2020 May;94:116-118. doi: 10.1016/j.ijid.2020.04.021. Epub 2020 Apr 19.
10
Covid-19 epidemic in Italy: evolution, projections and impact of government measures.意大利的新冠疫情:演变、预测和政府措施的影响。
Eur J Epidemiol. 2020 Apr;35(4):341-345. doi: 10.1007/s10654-020-00631-6. Epub 2020 Apr 18.